The CYP21A2 gene provides instructions for 21-hydroxylase, an enzyme in the adrenal glands that helps make cortisol and aldosterone, hormones that support stress response, blood pressure, and salt balance. This gene helps your body keep hormone levels in balance. When the CYP21A2 gene does not work properly, a person can develop congenital adrenal hyperplasia, which may cause dehydration, low blood pressure, early virilization, or earlier than expected puberty.
What is a gene?
Genes are sections of DNA that give cells instructions for making molecules or managing activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body grows and functions, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, see the LearnHub.
Overview
CYP21A2Gene function
What if the gene works
Your adrenal glands use the CYP21A2 gene to make an enzyme that helps produce cortisol and aldosterone. These hormones support stress response, blood pressure, and the body's salt and water balance.
Risk
What if the gene does not work
Variants in the CYP21A2 gene can reduce the body’s production of cortisol and, in some cases, aldosterone, causing congenital adrenal hyperplasia. Milder variants may cause later onset symptoms, while more severe variants often lead to earlier salt loss and extra androgens.
Treatment
What does that mean for your treatment
Pathogenic variants in the CYP21A2 gene usually mean treatment centers on hormone replacement, most often glucocorticoids, and often fludrocortisone with salt in more severe salt-wasting forms. Variant severity can help clinicians anticipate how much mineralocorticoid support may be needed and how closely to monitor treatment. Illness, injury, or surgery often calls for temporary stress dose steroids.
Conditions associated with CYP21A2
Gene function
What if the gene works
In the adrenal glands above your kidneys, the CYP21A2 gene helps your body make hormones you use every day. It gives cells the instructions for 21-hydroxylase, an enzyme that carries out key steps for making hormones. When it is working normally, adrenal cells can move hormone building blocks along the right path.
The CYP21A2 gene helps adrenal cells make cortisol through a key step in the hormone pathway. Cortisol supports everyday energy use, blood sugar control, and your body’s response to physical stress.
This gene also supports the making of aldosterone, another hormone made in the adrenal glands. Aldosterone helps your body keep the right balance of sodium, potassium, and water, which supports blood pressure.
Inside adrenal cells, its enzyme turns early hormone building blocks into the next forms needed for production. This is a central part of how the CYP21A2 gene helps make adrenal hormones in a steady, controlled way.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many CYP21A2 gene variants change how much 21-hydroxylase the cell can make or how well the enzyme works, often by altering its shape, stability, or ability to process hormone building blocks. Milder CYP21A2 gene variants may leave some enzyme activity, while more severe variants can lead to very little or none. This range helps explain why CYP21A2 variants and congenital adrenal hyperplasia can appear in milder or more pronounced forms.
How variants are linked to conditions
Variants in the CYP21A2 gene cause congenital adrenal hyperplasia (CAH), the main condition linked to CYP21A2 variants in medical practice. This includes classic and nonclassic 21-hydroxylase deficiency. Classic forms usually appear in infancy or childhood, while nonclassic forms may be recognized later, sometimes after early pubic hair, acne, irregular periods, or fertility problems. A pathogenic variant in both copies of the CYP21A2 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CYP21A2, risk is mostly set by the gene changes a person is born with, not by diet, exercise, or other lifestyle factors. The main thing that changes risk is family history and whether both parents carry a CYP21A2 change, which raises the chance of having a child with congenital adrenal hyperplasia.
Inheritance of CYP21A2 variants
CYP21A2-related conditions are usually inherited in an autosomal recessive pattern, which means a child typically inherits one CYP21A2 variant from each parent. In families asking about CYP21A2 gene inheritance, parents who each carry one variant are often healthy themselves, but with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. Because the CYP21A2 gene is on chromosome 6, this pattern affects males and females equally.
What does my CYP21A2 result mean for my family?
For CYP21A2, family implications are usually about carrier status. Brothers, sisters, and other close relatives may also be carriers or, less often, have the condition, especially if both parents carry a changed copy of the gene. For future children, the chance depends on whether both biological parents carry a CYP21A2 change.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the CYP21A2 gene usually uses a blood sample or saliva sample. A lab reads your DNA to look for variants linked with congenital adrenal hyperplasia, so CYP21A2 genetic testing for congenital adrenal hyperplasia can help confirm a diagnosis, clarify carrier status, or explain an unclear newborn screening result.
When should I consider getting a genetic test?
Genetic testing for the CYP21A2 gene can be helpful if a baby has an abnormal newborn screen or signs of congenital adrenal hyperplasia, such as vomiting, dehydration, poor weight gain, or unusual genital development. It may also be considered if this condition runs in the family, if a partner is known to carry a CYP21A2 change, or if an older child or adult has early puberty, irregular periods, or fertility problems.
A genetic result is only one part of your health story
How informative a genetic result is depends on both the condition and the type of variant involved, although it can offer meaningful insight. Over time, the way the body works is shaped by many influences, including lifestyle, environment, age, and medical history. In some conditions, particularly those influenced by many genes, genetic information gives context rather than certainty and is best interpreted alongside other parts of care. In other instances, a genetic result may give a clear answer. For topics such as medication response, genetic results can also help put a person’s experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work for them. It studies gene-drug patterns to better understand why the same treatment can act differently from one person to another. For many medicines, genes can influence both how strong a drug’s effect is and how the body processes it. This information can support more informed and more individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CYP21A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dosing, so questions about symptoms, treatment, steroid use, or medication side effects are best discussed with your doctor.
History
Throughout history, people described infants and children with features now recognized as congenital adrenal hyperplasia, long before the CYP21A2 gene was identified. In the mid 20th century, doctors linked many of these cases to a lack of 21-hydroxylase, which marked a major step in understanding the condition. From these first observations, research expanded steadily. By the 1980s, scientists mapped the CYP21A2 gene within a complex stretch of chromosome 6 near a closely related copied gene, helping explain why gene mix-ups and rearrangements are common. This work turned CYP21A2 into a landmark in medical genetics because it connected family patterns, hormone testing, and DNA findings in a much clearer way. Today, its history remains closely tied to newborn screening and earlier diagnosis of congenital adrenal hyperplasia.